Inflexion’s Rosemont Pharmaceuticals to acquire Aytu BioPharma in take-private deal

Aytu BioPharma is a Nasdaq-listed US specialty pharmaceutical company focused on medicines for complex central nervous system diseases.

3 minutes ago•1 min read
LinkedInXEmail
LinkedInXEmail

Related articles